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Appendix 1: Systematic search of the monetary value of an IQ point for an unborn 
cohort in a UK setting 
 
This appendix aims to identify and evaluate papers which can be used to estimate the monetary value of an IQ 
point increment. To properly reflect the true cost of IQ loss/gain from a programme applicable to the target 
population, careful consideration is needed on the sourcing and methodology behind the estimation of the 
monetary value of an IQ point. The findings are then applied to estimate the value of an IQ point for the unborn 
UK cohort in the iodine supplementation model. 
Methods 
Systematic search of the literature on the monetary value of IQ points 
A systematic search of the literature to determine the monetary value of an IQ point was undertaken following 
the UK Centre for Review and Dissemination guidelines for methods and Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines for reporting, where appropriate.
1,2 
 
Inclusion Criteria 
Articles were included if they met the following criteria: the study reports primary or secondary research on the 
monetary value of an IQ point gain/loss, or the study looks at the economic cost associated with IQ gain/loss. 
Search Strategy 
Four electronic databases were searched (EMBASE, MEDLINE, EconLit, and NHS Economic Evaluation 
Database) up to August 2014. In addition, the reference lists of potentially relevant articles were then manually 
searched and an exploration of grey literature consisting of internet searches with Google and Google scholar 
was conducted to identify additional studies. Search words included “Intelligence”, “IQ”, “cost benefit 
analysis”, “cognitive ability”, “willingness to pay”, “willingness to accept”, “economic evaluation”, “earnings”, 
and “income”. One author did the study selection and data extraction.  
A three stage process determined studies fit for inclusion, using methods described in detail elsewhere.
3
 The 
initial screening process used the title and abstract of an article to sort them into five groups A-E based on the 
relevance of each study to the systematic search: 
A. The study reports primary research on the monetary value of IQ point decrement/increment. 
B. The study reports secondary research on the monetary value of IQ point decrement/increment. 
C. Study found via grey literature searches.  
D. The study looks at the economic cost associated with IQ loss but do not in terms of IQ point 
decrements /increments. 
E. This study is not relevant to this systematic search. 
 
All studies categorised as A, B, C, or D were further classified after reading the full text into the following 
categories by type of study: 
1. Primary Research which details the methodology behind the monetary value of an IQ point.  
2. Secondary Research which details the methodology behind the monetary value of an IQ point.  
3. Only provides a reference from other literature on the monetary value of IQ point loss.  
4. Review of the literature which includes the costs associated with IQ loss. 
5. Decision analysis model using the cost of IQ loss as a parameter. 
6. Other, such as the costs associated with the shift in the population IQ distribution policy. decisions 
related to low IQ or the economic burden of neurodevelopmental disorders. 
7. The cognitive measure in the study cannot be used to determine the monetary value of an IQ point.  
8. Not applicable to this systematic search. 
Only studies that reported primary research on an IQ point were eligible for the quality criteria stage (A1s, B1s, 
& C1s). Finally, the following quality assessment criteria were applied to the studies to determine robust 
estimates of IQ point valuations for the iodine supplementation decision model:   
1. An individual’s IQ is used and is not a proxy. 
2. Variables are clearly specified.  
  
3. IQ measure follows a conventional normal distribution with a mean of 100 and standard deviation of 
15 or sufficient information is included in the study to allow the IQ measure’s distribution to be 
converted into one (for cross study comparability). 
4. The results reported in currency form have the applicable year stated. 
 
Studies fulfilling the quality criteria were eligible for inclusion. For each included study, data were extracted on 
the study characteristics, the intelligence measure used, the main results reported and covariates, if any. The data 
were tabulated, and the themes faced by the individual studies when estimating the value of an IQ point were 
compared narratively. 
Results 
The electronic database search identified 1361 published articles, of which 390 were rejected as duplicates. 
Appendix 1 Figure 1 shows a flow diagram of the articles identified, retrieved, and retained or excluded at each 
stage and the categorization of the articles. Eight studies passed all the quality criteria and were therefore 
considered for use in calculating the monetary value of an IQ point. The included studies are listed in Appendix 
1 Table 1. 
One study looked at people’s willingness to pay (WTP) for an additional IQ point.4 Five studies used 
econometric regressions to determine the individuals IQ’s effect on their subsequent income,5-9 whereas two 
studies were cost benefit analysis on reducing lead exposure.
10,11
 Only one of the studies included in the 
systematic literature search was not set in the USA.
5 
Direct or otherwise, all the econometric and cost benefit analysis studies valued an IQ point solely from its 
impact on earnings. Excluding the willingness to pay study, none of the studies considered IQ’s effect on health 
outcomes in its valuation. 
IQ’s effect on an individual’s future earnings 
When determining IQ’s causal effect on income, the included covariates are important. If a covariate is 
indirectly affected by someone’s intelligence, IQ’s effect on earnings will be understated. For example, 
Fletcher’s9 study inclusion of an academic achievement variable along with other cognitive related variables is 
likely to contribute to IQ not being a significant predictor of earnings in his model.    
The issue of whether to include number of years in education as a covariate is not clear-cut. Higher education 
leads to higher earnings which would overestimate IQ’s effect on earnings if not controlled for. However, 
education to a certain extent is a choice variable and dictated by someone’s intelligence.12 Thus, controlling for 
education ignores IQ’s indirect contribution on earnings via more years of schooling undertaken. Schwartz 10 
recognized that IQ’s indirect effects on earnings originate from the positive effect of a person’s IQ on years of 
schooling which subsequently affects the worker participation rate and earnings. He concluded that IQ’s total 
effects gave an additional 1.76% in earnings per additional IQ point.  
The earnings returns for an additional IQ point are not uniform across genders. Using more recent data than 
Schwartz’s10 estimates, Salkever11 found that the total effect on earnings per additional IQ point is 2·09% for 
men and 3·63% for women. In contrast, Mueller reported higher earnings returns from an additional IQ point for 
males rather than females. Salkever and Schwartz’s relatively high figures compared to other microeconomic 
papers on IQ and earnings have led to concerns that their reported effect of IQ on earnings is overstated;
13,14
 
Salkever
15
 has since responded to these concerns pointing out, among other things, the generalizability issues of 
the other studies and endogenity problems with studies using hourly wages as a dependent variable.  
Non cognitive ability is shown to have a significant effect on earnings.
7-9
 Non cognitive ability here relates to 
personality traits, social skills, motivation, and perseverance. Mueller & Plug
7
 utilised the Big Five Inventory 
(BFI) to capture personality traits and assess its effects in conjunction with IQ on earnings. After 
unstandardizing the IQ regression coefficient and controlling for personality traits, an additional IQ point 
increases hourly earnings by 0·69% and 0·48% for men and women respectively. Zagorsky
8
 reported that IQ 
score along with the Rotter locus of control, Rosenberg Self-esteem scale and Pearlin mastery scale were all 
significant in a robust income regression with an extensive array of covariates. An additional IQ point increases 
annual household income on average by $202 (2004 US dollars), around 0·56% of median household income in 
the study.  
Heckman and colleagues
12
 reported a positive correlation between cognitive and non-cognitive ability which 
would overestimate cognitive ability’s effect on earnings if non-cognitive ability is omitted from the regression. 
  
Unfortunately, their study did not pass the quality criteria as their standardized cognitive measures inhibited a 
valuation of an IQ point.  
The strength of IQ as a predictor of earnings appears to increase as people get older. In Zax and Rees’ study,6  an 
additional IQ point raised 35 year old male earnings by 0·75% whereas an additional IQ point raised earnings by 
1·4% when they were measured when the participants were in their fifties. After adjusting for years of 
education, the 35 year old earnings IQ coefficient falls to 0·46% and the 53 year old earnings falls to 0·61% 
respectively. 
Valuation of an IQ point based on people’s willingness to pay 
A product or service should be valued by how much people are willing to pay for it. The willingness to pay 
study assigned a much lower valuation of an IQ point (1996 USD $1,100-$1,900) than the econometric papers. 
This may reflect high discounting of the future by their respondents and/or the lack of awareness of the 
implications of IQ loss on future earnings and health states. Lutter
4
 also suggests that the low valuation may 
partly be due to the parents expecting poor returns in investing in their child’s human capital. 
Monetary Value of an IQ point to be used in the model 
In keeping with the conservative nature of the model, the relatively high earnings premium from IQ points from 
Schwartz 
10
 and Salkever 
11
 are excluded on the basis that the effect may be overstated. The base case 
percentage is taken to be 1%,  a rough average of the IQ’s effect on earnings at the two timepoints, not 
controlling for education, in the Zax and Rees
6
 study. A lower bound estimate of IQ’s effect on earnings for the 
sensitivity analysis is taken to be £1135 – an updated lower bound WTP for an IQ point in Lutter’s4 study. The 
lower bound WTP estimate was calculated by updating the study figure into 2013 US dollars and converting it 
to British pound sterling based on the 2013 rate of purchasing powers parities ($1 is equal to £0·70).
16
 
To estimate the value of the extra lifetime earnings for the unborn infants with higher IQ points, the average UK 
wage in 2013 —£24687— was taken from the labour force survey.17 Assuming real wages rises by 1% per 
annum and the UK Economically Active Rate (EAR) for 16-64 year olds stays constant (0·72),
17
 the Present 
Value of Lifetime Earnings (PVLE) for the infants, evaluated at time of birth, discounted at the recommended 
3·5% ,
18
 is £337736. The formula for estimating the PVLE for the unborn infants is displayed below:  
PVLE for unborn cohort = (PVLE up to 64 yrs. − PVLE up to 16 yrs.)× EAR  
Taking 1% as the base case percentage of the effect of an additional IQ point on earnings, this translates to a 
£3377 monetary value of an IQ point for this unborn cohort. Since not everyone survives until the age of 65, UK 
life tables are used in conjunction with the projected earnings to calculate a revised estimate of the value of an 
IQ point for this unborn cohort.
19
 This gives an adjusted estimate of £3297 for an IQ point value. 
Discussion 
The systematic search identified eight studies for the purposes of extracting a monetary value of an IQ point for 
the iodine supplementation model. Twelve other studies which contained primary research behind the monetary 
value of an IQ point did not pass all the quality criteria and therefore were excluded from the final analysis. One 
problem that prevented a lot of the papers from being included in the final analysis was the inability of using 
their cognitive measure due to scaling issues. The reported coefficients for the studies are standardized so as to 
convey the relative importance of each coefficient in comparable units. Insufficient information is given by the 
studies to enable transforming the IQ score coefficient back to the conventional IQ distribution. Adopting the 
standardizing approach is surprising, given that standardizing coefficients has attracted its share of criticism.
20
 
The monetary value of an IQ point assumes a linear effect on earnings that is not dependent on where on the IQ 
distribution an individual gaining an additional IQ point would start. Intuitively, we would expect an additional 
IQ point to be worth more for someone who has a borderline intellectual disability than someone from a higher 
IQ category. The Zax and Rees
6
 study participants were restricted to high school graduates and therefore, the 
IQ’s impact on earnings is likely to be an underestimate for people of lower educational ability who never 
progress to that educational attainment level. 
With questions about how much the participants are aware of the implications of an additional IQ point, the 
representativeness of the study sample to the general population and its applicability in a UK setting, using the 
willingness to pay figure for the iodine supplementation model would be far from ideal.  
Other studies which make use of a monetary value of an IQ point, such as environmental cost benefit analyses 
of health hazards, typically use an updated version of a monetary value of an IQ point calculation from one 
  
paper. Grosse and colleagues
21
 based their value on Schwartz’s estimate for IQ’s total impact on earnings and 
aimed to make it applicable to a two year old cohort. Simply updating their figure to the current year is not 
sufficient unless the cohort is of the same age. For example, their IQ monetary value would not be suitable for 
the iodine supplementation model as the cohort have yet to be born and the future benefits should be discounted 
more as they reach working age later than a two year old cohort. If a study is considering the costs of cognitive 
damage to society that affects a broad population base, a weighted average approach of the PVLE calculations 
across ages would be more appropriate than a cohort, albeit requiring more extensive workings. 
The ideal monetary value of the IQ point for the iodine supplementation from an earnings premium would be 
taken from a UK study with a representative cohort, panel data containing earnings over the years, variables 
controlling for non-cognitive skills and a valid IQ test with the conventional normal distribution. Likewise, a 
desirable willingness to pay figure would be a UK population representative sample with participants informed 
of the societal lifetime implications of an additional IQ point. Future research is welcomed towards improving 
the estimate in the systematic search for different country contexts.  
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Stage II categorisation: 91 
studies 
A(1)=16, A(4)=1, A(7)=14 
B(2)=11,  B(3)=4, B(4)=1, 
B(5)=5, B(6)=1, B(7)=4, C(1)=4, 
D(8)=30 
4 additional records identified 
through grey literature  
71 studies excluded: A(4),A(7), 
B(2),B(3), B(4), B(5),B(6),B(7), 
D(8) 
2 Full-text articles not accessible 
Stage I  
Initial Categorisation: 971 citations  
Studies included in the systematic 
search : 
(n=8) 
882 excluded on basis of 
title/abstract 
Electronic database search (MEDLINE 
411, EMBASE 523, EconLit 377, NHS 
EED 50) 1361 citations 
390 excluded as duplicates 
12 studies did not pass quality 
criteria (QC):  QC1=1, QC2=2, 
QC3=7, QC4=2 
 
Appendix 1 Figure 1: Prisma Diagram of the Monetary Value of an IQ point Systematic Search 
  
 
Appendix 1: Table 1 – Summary of Characteristics of included IQ papers   
Lead 
Author 
(Year) 
Type of study Population Dataset  Intelligence 
measure  
Dependent variable Result Key Covariates 
Fletcher9 
(2013) 
Econometric 
Analysis 
Men and Women in the 
USA 
National Longitudinal 
Study of Adolescent 
Health  
(Add Health) 
Peabody Picture 
Vocabulary Test 
(PPVT) 
Log of annual earnings  IQ has no effect on earnings Academic achievement, age, 
race, popularity, years of 
education, and personality 
Lutter4 
(2000) 
Revealed 
Preference 
Parents deciding on 
chelation therapy for 
their children in the USA 
Agee and Crocker 
(1996) data 
N/A N/A A willingness to pay of between 
$1,100 and $1,900 per IQ point 
gained for child 
N/A 
Mueller7 
(2006) 
Econometric 
Analysis 
Men and Women in 
Wisconsin, USA 
Wisconsin Longitudinal 
Study of Social and 
Psychological 
Factors in Aspiration and 
Attainment (WLS) 
Henmon-Nelson 
Test of Mental 
Ability 
Log hourly wages An increase of 0·69% and 0·48%  
in earnings per additional IQ point 
for men and women respectively 
Personality traits 
Salkever11 
(1995) 
 
Cost Benefit 
Analysis 
Men and Women in the 
USA 
National Longitudinal 
Survey of Youth 1979 
(NLSY79) 
Armed Forces 
Qualifications Test 
(AFQT) 
Log of annual earnings  An increase of 2·09% for men and 
3·63% for women in earnings per 
additional IQ point  
 
N/A 
Schwartz10 
(1994) 
Cost Benefit 
Analysis 
Men and Women in the 
USA 
National Longitudinal 
Survey of Youth 1979 
(NLSY79) 
Armed Forces 
Qualifications Test 
(AFQT) 
Log of annual earnings An increase of 1·76% in earnings 
per additional IQ point  
N/A 
de Wolff5 
(1973) 
Econometric 
Analysis 
Men and Women in 
Sweden 
Malmö Longitudinal 
Study 
Swedish Military IQ 
test 
Log of annual earnings An increase of 0·4% of earnings 
per additional IQ point 
Social Class, Educational 
Performance, and Civil 
Status. 
Zax6 
(2002) 
Econometric 
Analysis 
Men in Wisconsin, USA Wisconsin Longitudinal 
Study of Social and 
Psychological 
Factors in Aspiration and 
Attainment (WLS) 
Henmon-Nelson 
Test of Mental 
Ability 
Log of earnings when 
subjects aged 35 and  log of 
earnings when subjects aged 
53  
An increase of 0·75% for 35 year 
olds and 1·40% for 53 year olds in 
earnings per additional IQ point  
None 
Zagorsky8 
(2007) 
 
Econometric 
Analysis 
Men and Women in USA National Longitudinal 
Survey of Youth 1979 
(NLSY79) 
Armed Forces 
Qualifications Test 
(AFQT) 
Annual household income  An increase of $202 to $616 in 
annual household income per 
additional IQ point 
Age, race, net worth, non-
cognitive ability and 
education 
  
Appendix 2: List of Sensitivity Analysis scenarios for the iodine supplementation model  
This appendix describes the sensitivity analysis scenarios employed to assess the stability of base case results. 
1. Sensitivity Analysis related to IQ gain 
As the IQ gain for the children whose mothers would have been iodine deficient without supplementation is 
likely to vary, we carried out three separate sensitivity analysis scenarios. This was also done to relax the 
assumption of perfect adherence to iodine supplementation.  
(i) We reduced the IQ point gain for the children of severely iodine deficient expectant mothers in the 
iodine supplementation strategy to be the same IQ gain experienced by the children of 
mildly/moderately iodine deficient mothers;  
(ii)  We reduced the IQ gain from iodine supplementation to a single IQ point for children of iodine 
deficient mothers; and  
(iii)  We assumed no IQ gain for children of mildly / moderately iodine deficient mothers.  
 
2. Sensitivity Analysis related to Iodine Supplementation   
The uncertainty around the prevalence of iodine deficiency in pregnant women and the cost of supplementation 
was arbitrarily tested by: 
(iv) halving the prevalence of iodine deficient pregnant women.  
(v) doubling the baseline early pregnancy loss. 
(vi) doubling the cost of iodine tablets 
(vii) doubling the discount rate. Increasing the discount rate reduces the value of benefits and costs that 
accrue in the future. 
(viii) removing the assumption of thyroid dysfunction being caused by supplementation. This was done 
as there is no evidence of thyroid dysfunction caused by iodine supplementation in pregnant 
women.
1
 
(ix) halving the health cost savings from IQ gains for Analysis 1 (Health Service perspective) only.  
Changes in Analysis 2 (societal perspective) only: 
In terms of the monetary value of an IQ point, a lower estimate was investigated by: 
(x) halving the earnings benefit per IQ point gain.  
(xi) modifying an assumption to allow for no real wage growth. Real wage growth in the UK in the 
2000’s increased by 1·2% on average annually but this trend has reversed and since the first three 
months of 2010, real wage growth has fallen by 2·2% per annum.
2
   
(xii) substituting an updated willingness to pay figure identified in the systematic search     (see 
Appendix 1). This was done to allay any concerns about using earnings as a basis for the value of 
an IQ point. 
(xiii) excluding public sector costs savings. 
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Appendix 3: Reduction in the proportion of children in the lower IQ categories  
The benefits in increasing IQ in the model come largely from the health and education savings arising from 
fewer children in the lower IQ categories. Below are the steps we took to calculate how many fewer children 
would be in the lower IQ categories as result of the iodine supplementation strategy. 
We assume IQ follows the conventional normal distribution with a mean of 100 and the standard deviation of 
15. To calculate the proportion of a child in an IQ category, we use Z scores.  
The Z score of being in the IQ category of 70 and below: 
(70−100)
15
= −2.00 
A Z score of -2.00 corresponds to a probability of 2·28% 
The Z score of being in the IQ category of 81 and below: 
(81−100)
15
= −1 · 26̇  
A Z score of −1 · 26̇   corresponds to a probability of 10·26% 
The Z score of being in the IQ category of 92 and below: 
(92−100)
15
= −0 · 53̇  
A Z score of −0 · 53̇  corresponds to a probability of 29·69% 
An increase of IQ as a result of iodine supplementation for the mildly/moderately iodine deficient expectant 
women is assumed to be 2·2 IQ points. This raises the mean IQ from 100 to 102·2. 
The Z score of being in the IQ category of 70 and below: 
(70−102·2)
15
= −2 · 15 
A Z score of -2 · 15  corresponds to a probability of 1·59% 
The Z score of being in the IQ category of 81 and below: 
(81−102·2)
15
= −1 · 41  
A Z score of −1 · 41   corresponds to a probability of 7·88% 
The Z score of being in the IQ category of 92 and below: 
(92−102·2)
15
= −0 · 68  
A Z score of −0 · 68 corresponds to a probability of 24·83% 
The reduction of children in the lower IQ categories as a result of iodine supplementation for the 
mildly/moderately iodine deficient expectant women are as follows: 
The probability of being in the IQ category of 70 and below is reduced by 0·69% (2·28%-1·59%). 
The probability of being in the IQ category of 81 and below is reduced by 2·38% (10·26%-7·88%). 
The probability of being in the IQ category of 92 and below is reduced by 4·86% (29·69%-24·83%). 
The probability of being in the 71-81 IQ category is the probability of being in the IQ category of 81 and below 
minus the probability of being in the IQ category of 70 and below.  The reduced probability of being in the 71-
81 IQ category is 1·69% (2·38%-0·69%). 
The probability of being in the 82-92 IQ category is the probability of being in the IQ category of 92 and below 
minus the probability of being in the IQ category of 81 and below.  The reduced probability of being in the 82-
92 IQ category is 2·48% (4·86% - 2·38%). 
These calculations were also done in the model for the severely iodine deficient IQ gain of 3·0 and the IQ loss 
of 7 from hypothyroidism induced by iodine supplementation. 
 
 
  
Appendix 4: Probabilistic Sensitivity Analysis Results 
Probabilistic Sensitivity Analysis (PSA) assesses parameter uncertainty in base case results.   Distributions are 
placed around the point estimate of each parameter.  The distributions and their parameters used for each 
variable are listed in Appendix 4 Table 1. Gamma distributions are used for costs, log-normal distributions for 
odds ratios, beta distributions for probabilities, and dirichlet distributions for proportions that have more than 
two mutually exclusive outcomes.  
The model was run for 10,000 iterations, sampling from all distributions simultaneously. The results are 
presented in the form of cost effectiveness scatterplots for the two separate analysis perspectives in Figure 1 and 
Figure 2 of this Appendix. Cost effectiveness scatterplots show the uncertainty in the costs and IQ gains from 
iodine supplementation. The vast majority of the points in the graphs lie in the south east quadrant of a cost 
effectiveness plane –meaning the iodine supplementation strategy is cost saving with a net gain to IQ points. 
However, we would urge caution in interpreting the PSA for this model as it is misrepresentative of the 
variability given the choices used for the base case results.  The parameters we use for the base case results 
reflect a worst case scenario where a true characterization of parameter uncertainty requires more central 
estimates for the PSA. As the base results would be more cost saving using more central estimates, the spread of 
uncertainty in the PSA would be more in this south east quadrant.  
 
Appendix 4 Table 1: Parameters and their distributions for the PSA 
Variable Name Distribution Parameters 
Proportion of iodine deficient women who are severely iodine deficient    Beta 
α= 65 
β= 526 
Iodine deficiency split: 
(Iodine replete expectant mothers; Iodine deficient expectant mothers; Thyroid 
dysfunction expectant mothers) 
 Dirichlet 
 
 
 
 
(α1;α2;α3) = (2;646;310) 
IQ gain from supplementation in previously mildly iodine deficient women Gamma 
α= 1 
β= 0·45 
IQ gain from supplementation in previously severely iodine deficient women  
Gamma 
α= 1 
β= 0·33 
IQ loss from overt & subclinical hypothyroidism , and isolated 
hypothyroxinemia Gamma 
α= 1 
β= 0·14 
Public sector costs of preterm birth Gamma 
α= 6·02 
β= 5537·06 
Health sector costs of preterm birth Gamma 
α= 15·70 
β= 2075·29 
Incremental annual health and social services cost for children in 82-92 IQ 
points category 
Gamma 
α= 6·10 
β= 88·26 
Incremental annual health and social services cost for children in 71-81 IQ 
points category 
Gamma 
α= 6·75 
β= 131·99 
Incremental annual health and social services cost for children in 70 and below 
IQ points category 
Gamma 
α= 2·97 
β= 486·81 
Baseline pregnancy risk of early pregnancy loss 
Beta 
α= 2 
β= 8 
Baseline pregnancy risk of stillbirth Beta α= 3284 
β= 695228 
Baseline pregnancy risk of preterm birth Beta α= 51397 
β= 668227 
Baseline pregnancy risk of pre-eclampsia Beta α= 2 
β= 23 
Incidence of early pregnancy loss from overt hyperthyroidism  Beta α= 13 
β= 37 
Odds ratio of stillbirth from overt hyperthyroidism 
Log Normal* 
µ= 2·13 
σ= 0·73 
Odds ratio of preterm birth from overt hyperthyroidism  
Log Normal* 
µ= 2·80 
σ= 1·05 
Odds ratio of pre-eclampsia from overt hyperthyroidism  
Log Normal* 
µ= 1·37 
σ= 0·24 
Incidence of early pregnancy loss from overt hypothyroidism  Beta α= 3 
β= 7 
  
Odds ratio for stillbirth from Overt Hypothyroidism  Log Normal* µ= 2·27 
σ= 0·61 
Odds ratio for Preterm Birth from Overt Hypothyroidism  Log Normal* µ=  2·74 
σ= 0·74 
Incidence of pre-eclampsia from Overt Hypothyroidism  Beta α= 3 
β= 7 
Odds ratio for early pregnancy loss from subclinical hypothyroidism  Log Normal* µ= 0·63 
σ= 0·26 
Odds ratio for stillbirth from subclinical hypothyroidism Log Normal* µ= 1·19 
σ = 0·47 
Odds ratio for preterm birth from subclinical hypothyroidism  Log Normal* µ=  1·72 
σ = 0·45 
Odds ratio for pre-eclampsia from subclinical hypothyroidism  Log Normal* µ=  1·22 
σ = 0·45 
Odds ratio for preterm birth from isolated hypothyroxinemia  Log Normal* µ=  0·93 
σ = 0·30 
Split of Thyroid dysfunction 
(Overt hyperthyroidism; Overt hypothyroidism; Subclinical hypothyroidism; 
Isolated hypothyroxinemia) 
 Dirichlet 
 
 
 
 
(α1;α2;α3) = (25;25;25;25) 
*For the lognormal distributions, µ is the mean and σ is the standard deviation of the underlying normal distribution which gives the 
logarithm of the model parameter. 
 
Appendix 4 Figure 1 Cost effectiveness scatterplot (NHS perspective) 
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Appendix 4 Figure 2 Cost effectiveness scatterplot (Societal perspective) 
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